SLGL

Sol-Gel Technologies Ltd

Sep 17 • 11:36AM ET

23.87

-0.28 -1.15 %

Healthcare • Biotechnology • Israel • NASD

Peers: ANAB MCRB MRNS PTGX XAIR PRQR CRBP

Index	-	P/E	-	EPS (ttm)	-1.22	Insider Own	70.00%	Shs Outstand	2.79M	Perf Week	-0.33%
Market Cap	66.51M	Forward P/E	-	EPS next Y	-	Insider Trans	0.00%	Shs Float	0.84M	Perf Month	48.27%
Enterprise Value	43.40M	PEG	-	EPS next Q	-	Inst Own	28.74%	Short Float	2.98%	Perf Quarter	239.09%
Income	-3.41M	P/S	2.78	EPS this Y	-	Inst Trans	31.38%	Short Ratio	1.28	Perf Half Y	318.96%
Sales	23.93M	P/B	2.09	EPS next Y	-	ROA	-8.39%	Short Interest	0.03M	Perf YTD	156.66%
Book/sh	11.44	P/C	2.74	EPS next 5Y	-	ROE	-10.21%	52W High	30.00 -20.43%	Perf Year	278.92%
Cash/sh	8.72	P/FCF	-	EPS past 3/5Y	- 21.32%	ROIC	-10.47%	52W Low	4.01 495.91%	Perf 3Y	-58.84%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	-28.28% -12.81%	Gross Margin	-	Volatility	6.37% 13.31%	Perf 5Y	-68.26%
Dividend TTM	-	EV/Sales	1.81	EPS Y/Y TTM	77.14%	Oper. Margin	-19.92%	ATR (14)	2.10	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	7.32	Sales Y/Y TTM	264.86%	Profit Margin	-14.25%	RSI (14)	57.88	Recom	2.00
Dividend Gr. 3/5Y	- -	Current Ratio	7.32	EPS Q/Q	487.57%	SMA20	-0.41%	Beta	1.26	Target Price	40.00
Payout	-	Debt/Eq	0.04	Sales Q/Q	217.71%	SMA50	42.33%	Rel Volume	0.97	Prev Close	24.15
Employees	34	LT Debt/Eq	0.02	Earnings	Aug 15 BMO	SMA200	152.40%	Avg Volume	19.51K	Price	23.87
IPO	Feb 01, 2018	Option/Short	No / Yes	EPS/Sales Surpr.	- -	Trades		Volume	6,748	Change	-1.15%

Date	Action	Analyst	Rating Change	Price Target Change
Aug-19-24	Downgrade	Raymond James	Strong Buy → Outperform	$6 → $4
Oct-21-22	Resumed	Jefferies	Hold	$5.50
Dec-31-19	Reiterated	JMP Securities	Mkt Outperform	$20 → $33
Dec-31-19	Reiterated	H.C. Wainwright	Buy	$23 → $26

Sep-04-25 07:00AM	Sol-Gel Announces Health Canada Approval of EPSOLAY (GlobeNewswire) +19.66%
Aug-15-25 07:00AM	Sol-Gel Reports Second Quarter 2025 Financial Results and Provides Corporate Updates (GlobeNewswire)
May-23-25 07:15AM	Sol-Gel Reports First Quarter 2025 Results (GlobeNewswire)
May-01-25 07:00AM	Sol-Gel Announces Reverse Share Split (GlobeNewswire)
Apr-17-25 08:40AM	Sol-Gel and Mayne Pharma Announce the Purchase of EPSOLAY and TWYNEO in the U.S. (GlobeNewswire) +14.58%
12:00PM	Loading…
Nov-20-24 12:00PM	SolGel Technologies (SLGL) Upgraded to Buy: Here's What You Should Know (Zacks)
07:00AM	Sol-Gel Announces 180-Day Extension to Regain Compliance with Nasdaq Minimum Bid Requirement (GlobeNewswire)
Nov-15-24 08:10AM	Sol-Gel Technologies Ltd. (SLGL) Reports Q3 Loss, Tops Revenue Estimates (Zacks)
07:00AM	Sol-Gel Reports Third Quarter 2024 Financial Results and Provides Corporate Updates (GlobeNewswire)
Sep-17-24 09:55AM	SolGel Technologies (SLGL) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now (Zacks)
Aug-27-24 12:00PM	All You Need to Know About SolGel Technologies (SLGL) Rating Upgrade to Strong Buy (Zacks) +10.22%
Aug-17-24 11:27AM	UPDATE: Sol-Gel Reports Second Quarter 2024 Financial Results and Provides Corporate Updates (GlobeNewswire)
Aug-16-24 08:10AM	Sol-Gel Technologies Ltd. (SLGL) Surpasses Q2 Earnings and Revenue Estimates (Zacks)
07:00AM	Sol-Gel Reports Second Quarter 2024 Financial Results and Provides Corporate Updates (GlobeNewswire)
Jul-25-24 07:00AM	Sol-Gel Announces the Signing of Six Exclusive License Agreements to Commercialize TWYNEO® and EPSOLAY® in Europe and South Africa (GlobeNewswire) -32.85%
07:00AM	Loading…
Jul-15-24 07:00AM	Sol-Gel Technologies Announces Management Realignment (GlobeNewswire) -8.13%
May-28-24 07:00AM	Sol-Gel Announces Receipt of Nasdaq Minimum Price Notice (GlobeNewswire)
May-20-24 01:53PM	SLGL Stock Earnings: Sol-Gel Technologies Misses EPS, Misses Revenue for Q1 2024 (InvestorPlace) -6.00%
08:10AM	Sol-Gel Technologies Ltd. (SLGL) Reports Q1 Loss, Lags Revenue Estimates (Zacks)
07:00AM	Sol-Gel Reports First Quarter 2024 Financial Results and Provides Corporate Updates (GlobeNewswire)
May-16-24 06:00AM	Sol-Gel and Beimei Pharma Announce an Asset Purchase Agreement to Commercialize TWYNEO in the Mainland of China, Hong Kong, Macau, Taiwan and Israel (GlobeNewswire) +5.65%
Apr-01-24 07:00AM	Sol-Gel's Collaboration Partner First-to-File ANDA Drug Product Generic to Zoryve Cream (GlobeNewswire)
Mar-13-24 07:00AM	Sol-Gel Reports Full-Year 2023 Financial Results and Corporate Developments (GlobeNewswire)
Nov-30-23 07:00AM	Sol-Gel Technologies Screens First Patient for SGT-610 Phase 3 Study (GlobeNewswire)
Nov-28-23 08:06AM	Sol-Gel Technologies Ltd to Host Virtual KOL Event on Gorlin Syndrome and the Upcoming Phase 3 Trial for SGT-610 (GlobeNewswire)
Nov-09-23 07:00AM	Sol-Gel Technologies Reports Third Quarter 2023 Financial Results and Provides Corporate Update (GlobeNewswire)
Oct-31-23 06:43AM	Zacks Industry Outlook Highlights Dr. Reddy's Laboratories, Amphastar Pharmaceuticals and Sol-Gel Technologies (Zacks)
Oct-30-23 10:05AM	3 Generic Drug Stocks to Watch Amid Improving Market Prospects (Zacks)
Aug-30-23 08:00AM	Sol-Gel Technologies to Participate in the H.C. Wainwright 25th Annual Global Investment Conference (GlobeNewswire)
Aug-10-23 08:15AM	Sol-Gel Technologies Ltd. (SLGL) Reports Q2 Loss, Lags Revenue Estimates (Zacks)
07:00AM	Loading…
07:00AM	Sol-Gel Technologies Reports Second Quarter 2023 Financial Results and Provides Corporate Update (GlobeNewswire)
Jul-21-23 06:04AM	Sol-Gel Technologies Ltd.'s (NASDAQ:SLGL) Top Key Executive Moshe Arkin is the most upbeat insider, and their holdings increased by 15% last week (Simply Wall St.) +6.20%
Jun-06-23 07:30AM	Sol-Gel and Searchlight Pharma Announce Licensing Agreements to Commercialize TWYNEO® and EPSOLAY® in Canada (Business Wire)
Jun-02-23 06:09AM	Shareholders in Sol-Gel Technologies (NASDAQ:SLGL) are in the red if they invested five years ago (Simply Wall St.)
May-12-23 08:25AM	Sol-Gel Technologies Ltd. (SLGL) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
07:00AM	Sol-Gel Technologies Reports First Quarter 2023 Financial Results and Provides Corporate Update (GlobeNewswire)
Apr-22-23 08:19AM	Companies Like Sol-Gel Technologies (NASDAQ:SLGL) Can Afford To Invest In Growth (Simply Wall St.)
Mar-22-23 05:43AM	Load Up, Says Raymond James About These 3 Strong Buy Stocks (TipRanks) +14.69%
Mar-20-23 07:00AM	Sol-Gel Technologies to Present at the H.C. Wainwright Autoimmune & Inflammatory Disease Virtual Conference (GlobeNewswire)
Mar-15-23 11:44AM	7 Biotech Stocks That Could Be the Next Big Thing (InvestorPlace)
Mar-12-23 08:23AM	Sol-Gel Technologies Full Year 2022 Earnings: Misses Expectations (Simply Wall St.)
Mar-10-23 08:15AM	Sol-Gel Technologies Ltd. (SLGL) Reports Q4 Loss, Lags Revenue Estimates (Zacks)
07:00AM	Sol-Gel Reports Full-Year 2022 Financial Results and Corporate Developments (GlobeNewswire)
Feb-27-23 06:02AM	Could The Market Be Wrong About Sol-Gel Technologies Ltd. (NASDAQ:SLGL) Given Its Attractive Financial Prospects? (Simply Wall St.) +6.02%
Feb-23-23 02:32PM	The Top 7 Penny Stocks to Invest in for the Long-Term (InvestorPlace) -6.35%
Jan-27-23 07:29AM	Sol-Gel Announces Aggregate $22.8 Million Concurrent Registered Direct and Private Placement Offerings (GlobeNewswire)
07:00AM	Sol-Gel Acquires Patidegib, a Phase 3, FDA-Breakthrough-Designated Orphan Product Candidate to Pursue Potential Market of Over $300 Million (GlobeNewswire)
Dec-08-22 06:16AM	Zacks Industry Outlook Highlights Dr. Reddy's, Amphastar Pharmaceuticals and Sol-Gel Technologies (Zacks)
Dec-07-22 10:52AM	3 Generic Drug Stocks to Watch Amid Inflation Pressures (Zacks)
Nov-10-22 04:00AM	Sol-Gel Technologies Reports Third Quarter 2022 Financial Results and Provides Corporate Update (GlobeNewswire)
Nov-03-22 03:03PM	Sol-Gel Technologies (NASDAQ:SLGL) investors are sitting on a loss of 45% if they invested a year ago (Simply Wall St.)
Oct-03-22 08:00AM	Sol-Gel Technologies Appoints Michael Glezin Vice President, Business Development (GlobeNewswire)
Sep-19-22 01:00PM	Are Strong Financial Prospects The Force That Is Driving The Momentum In Sol-Gel Technologies Ltd.'s NASDAQ:SLGL) Stock? (Simply Wall St.)
Sep-12-22 04:30AM	Zacks Industry Outlook Highlights Teva, Dr. Reddy's and Sol-Gel (Zacks)
Sep-09-22 12:13PM	3 Generic Drug Stocks to Watch Amid Continued Pricing Pressure (Zacks)
Aug-04-22 06:00AM	Sol-Gel Technologies Reports Second Quarter 2022 Financial Results and Provides Corporate Update (GlobeNewswire) -6.64%
Jun-01-22 08:00AM	Sol-Gel Technologies to Participate in the 2022 Jefferies Global Healthcare Conference (GlobeNewswire)
May-27-22 11:45AM	Investors in Sol-Gel Technologies (NASDAQ:SLGL) have unfortunately lost 43% over the last year (Simply Wall St.) +6.53%
May-17-22 07:00AM	Sol-Gel Technologies to Present in Upcoming H.C. Wainwright Global Investment Conference (GlobeNewswire)
May-13-22 07:00AM	Sol-Gel Technologies Reports First Quarter 2022 Financial Results and Provides Corporate Update (GlobeNewswire) +6.00%
Apr-25-22 07:00AM	Sol-Gel Technologies and Galderma Announce FDA Approval of EPSOLAY® (GlobeNewswire) -7.61%
Apr-14-22 08:30AM	Sol-Gel Technologies Announces the Commercial Availability of TWYNEO® (GlobeNewswire) +9.94%
Apr-12-22 11:26AM	Are Sol-Gel Technologies Ltd.'s (NASDAQ:SLGL) Fundamentals Good Enough to Warrant Buying Given The Stock's Recent Weakness? (Simply Wall St.)
Mar-30-22 07:00AM	Sol-Gel Technologies Reports Full Year 2021 Financial Results and Corporate Developments (GlobeNewswire)
Mar-25-22 11:00AM	Sol-Gel Technologies Announces U.S. Commercial Partner Galderma to Promote TWYNEO® at the American Academy of Dermatology Annual Meeting to be Held March 25-29 in Boston, MA (GlobeNewswire)
Dec-22-21 04:05PM	Sol-Gel Technologies to Participate in Upcoming LifeSci Partners Corporate Access Event and H.C. Wainwright BioConnect 2022 Healthcare Conference (GlobeNewswire)
Dec-21-21 07:00AM	Sol-Gel Technologies Announces Positive Update Related to FDA Review Status of EPSOLAY® (GlobeNewswire)
Nov-30-21 08:27AM	Shareholders in Sol-Gel Technologies (NASDAQ:SLGL) have lost 23%, as stock drops 12% this past week (Simply Wall St.) +9.10%
Nov-11-21 07:00AM	Sol-Gel Technologies Reports Third Quarter 2021 Financial Results and Highlights Recent Corporate Developments (GlobeNewswire)
Nov-09-21 07:05AM	Sol-Gel Technologies to Present Live at Jefferies London Healthcare Conference (GlobeNewswire)
Nov-04-21 07:30AM	Sol-Gel Technologies Announces Sale of Generic Dermatology Portfolio to Partner Padagis for $21 Million (GlobeNewswire)
Oct-01-21 12:14PM	Will Sol-Gel Technologies (NASDAQ:SLGL) Spend Its Cash Wisely? (Simply Wall St.)
Sep-22-21 07:30AM	Sol-Gel Technologies to Present at Upcoming Cantor Virtual Global Healthcare Conference (GlobeNewswire) -6.09%
Sep-09-21 08:30AM	Sol-Gel Technologies to Present at Upcoming H.C. Wainwright Global Investment Conference (GlobeNewswire)
Aug-17-21 01:30PM	What Is The Ownership Structure Like For Sol-Gel Technologies Ltd. (NASDAQ:SLGL)? (Simply Wall St.)
Aug-04-21 07:05AM	Sol-Gel Technologies Reports Second Quarter 2021 Financial Results and Highlights Recent Corporate Developments (GlobeNewswire) -5.67%
Jul-27-21 10:26AM	Sol-Gel Wins FDA Approval For Fixed-Dose Combination Of Tretinoin, Benzoyl Peroxide For Acne Vulgaris (Benzinga)
09:15AM	Sol-Gel Technologies Announces FDA Approval of TWYNEO® (GlobeNewswire)
Jul-20-21 07:05AM	Sol-Gel Technologies to Report Second Quarter 2021 Financial Results on August 4th, 2021 (GlobeNewswire)
Jun-28-21 05:10AM	Sol-Gel Announces Pipeline Update and Future Development Plans (GlobeNewswire) -6.79%
05:00AM	Sol-Gel Technologies and Galderma Announce Exclusive Licenses for the Commercialization of EPSOLAY® and TWYNEO® in the United States (Business Wire)
May-27-21 07:00AM	Sol-Gel Technologies to Present at Upcoming Jefferies Healthcare Conference and Raymond James Human Health Innovation Conference (GlobeNewswire)
May-18-21 09:27AM	Does Sol-Gel Technologies' (NASDAQ:SLGL) Share Price Gain of 23% Match Its Business Performance? (Simply Wall St.)
May-13-21 07:05AM	Sol-Gel Technologies Reports First Quarter 2021 Financial Results and Corporate Update (GlobeNewswire) +15.19%
Apr-28-21 08:41PM	SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors Sol-Gel Technologies Ltd. - SLGL (Newsfile) -6.33%
Apr-27-21 02:20PM	Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Sol-Gel Technologies Ltd. (SLGL) Investigation (ACCESSWIRE) -12.66%
10:02AM	Sol-Gel Technologies Provides Update on FDA Review of EPSOLAY® (GlobeNewswire)
Mar-19-21 06:56AM	Sol-Gel Technologies (NASDAQ:SLGL) Is In A Good Position To Deliver On Growth Plans (Simply Wall St.)
Mar-10-21 10:29AM	Raymond James: These 3 Stocks Are Poised to Surge by at Least 50% (TipRanks) +10.79%
Mar-04-21 07:05AM	Sol-Gel Technologies Reports Full Year 2020 Financial Results and Corporate Update (GlobeNewswire) -8.42%
Feb-24-21 07:05AM	Sol-Gel Technologies to Present at Upcoming 2021 Raymond James Institutional Investors Conference and H.C. Wainwright Global Life Sciences Conference (GlobeNewswire) -5.24%
Jan-18-21 07:49AM	Have Insiders Been Buying Sol-Gel Technologies Ltd. (NASDAQ:SLGL) Shares? (Simply Wall St.)
Jan-11-21 07:05AM	Sol-Gel Technologies to Present at Upcoming 2021 Solebury Trout Virtual Investor Conference and H.C. Wainwright BioConnect Conference (GlobeNewswire)
Dec-07-20 07:05AM	Sol-Gel Technologies Announces FDA Acceptance for Filing of New Drug Application for Twyneo® for the Treatment of Acne Vulgaris (GlobeNewswire)
Dec-01-20 08:33AM	Sol-Gel Technologies (SLGL) Looks Good: Stock Adds 8.8% in Session (Zacks)
Nov-18-20 12:08AM	What You Need To Know About The Sol-Gel Technologies Ltd. (NASDAQ:SLGL) Analyst Downgrade Today (Simply Wall St.)
Nov-16-20 01:25AM	Sol-Gel Technologies Ltd. (NASDAQ:SLGL) Just Reported And Analysts Have Been Cutting Their Estimates (Simply Wall St.)
Nov-12-20 08:21AM	Recap: Sol-Gel Technologies Q3 Earnings (Benzinga)
07:05AM	Sol-Gel Technologies Reports Third Quarter 2020 Financial Results and Corporate Update (GlobeNewswire)
Nov-09-20 07:05AM	Sol-Gel to Present at Upcoming Healthcare Investor Conferences in November 2020 (GlobeNewswire)

Sol-Gel Technologies Ltd. operates as a clinical-stage dermatology company, which engages in the identification, development, and commercialization of topical dermatological drug products for the treatment of skin diseases. Its products include VERED, TWIN, and SIRS-T. The company was founded by David Avnir and Alon Seri-Levy on October 28, 1997 and is headquartered in Ness Ziona, Israel.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

SLGL

Sol-Gel Technologies Ltd

Upgrade your FINVIZ experience